uniQure (QURE)
(Delayed Data from NSDQ)
$10.12 USD
+3.45 (51.72%)
Updated Jul 10, 2024 04:00 PM ET
Pre-Market: $10.12 0.00 (0.00%) 8:22 AM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
QURE 10.12 +3.45(51.72%)
Will QURE be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for QURE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QURE
Wall Street Analysts Think uniQure (QURE) Could Surge 195.8%: Read This Before Placing a Bet
uniQure (QURE) Soars on New Huntington's Disease Study Data
QURE: What are Zacks experts saying now?
Zacks Private Portfolio Services
uniQure (QURE) Surges 76.5%: Is This an Indication of Further Gains?
Down -29.74% in 4 Weeks, Here's Why You Should You Buy the Dip in uniQure (QURE)
UniQure (QURE) Reports Q4 Loss, Tops Revenue Estimates
Other News for QURE
uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
uniQure Shareholders Approve Board and Financial Decisions
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease
uniQure’s Gene Therapy Earns FDA Advanced Therapy Designation
uniQure receives RMAT designation of AMT-130 in Huntington's Disease